| Authors: |
Doroshow DB; Yale Cancer Center, New Haven, Connecticut, USA., Shapiro GI; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Do K; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Keedy VL; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Mahdi H; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Sohal DPS; Cleveland Clinic, Cleveland, Ohio, USA., Hafez N; Yale Cancer Center, New Haven, Connecticut, USA., LoRusso PM; Yale Cancer Center, New Haven, Connecticut, USA., Cecchini M; Yale Cancer Center, New Haven, Connecticut, USA., Sklar J; Yale Cancer Center, New Haven, Connecticut, USA., Mortimer P; AstraZeneca, Cambridge, Massachusetts, USA., Glover C; AstraZeneca, Cambridge, Massachusetts, USA., Moses J; Yale Cancer Center, New Haven, Connecticut, USA., Jürgensmeier JM; Yale Cancer Center, New Haven, Connecticut, USA.; Independent Consultant., Eder JP; Yale Cancer Center, New Haven, Connecticut, USA. |
